Skip to main content

Christina Rossi

Equibles does not estimate personal net worth.

Get an email with a short summary when CG Oncology, Inc. publishes a filing, an earnings call transcript or a press release.

Get CGON alerts

About Christina Rossi

Christina Rossi is recorded as Board Member at CG Oncology, Inc. (CGON). The newest filing on record that lists Christina Rossi as Board Member at CG Oncology, Inc. (CGON) is dated April 24, 2026. Xilio Therapeutics, Inc. reported in an 8-K filed April 16, 2026 that Christina Rossi resigned as Board and all committees thereof, effective April 15, 2026. The same filing states: “Ms. Rossi’s resignation did not result from any disagreement with the Company or its management.” CG Oncology, Inc. reported in an 8-K filed November 26, 2025 that Christina Rossi was appointed Class II director, effective November 24, 2025. CG Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CG Oncology, Inc. includes Arthur Kuan (CEO), Corleen M. Roche (CFO), Jim DeTore (CFO) and 4 others.

“Dr. Blanchard succeeds Christina Rossi, who notified the Company of her decision to resign from the Board and all committees thereof on April 15, 2026, effective as of such date.”
“Ms. Rossi’s resignation did not result from any disagreement with the Company or its management.”
Xilio Therapeutics, Inc. Form 8-K, filed April 16, 2026 · Read the filing
“On November 22, 2025, the Board of Directors (the "Board") of CG Oncology, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Christina Rossi to the Company's Board, effective November 24, 2025.”
CG Oncology, Inc. Form 8-K, filed November 26, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at CG Oncology, Inc.

Recent activity